Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

被引：23
|
作者：
Huff-Hardy, Kayci [1 ]
Bedair, Mai [2 ]
Vazquez, Rebecca [2 ]
Burstein, Ezra [1 ]
机构：
[1] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
[2] UT Southwestern Med Ctr, Dept Dermatol, Dallas, TX USA
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷 / 10期
关键词：
MAINTENANCE THERAPY; INDUCTION;
D O I：
10.1097/MIB.0000000000001232
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E49 / E49
页数：1
相关论文
共 50 条
  • [21] COMPARISON OF SHORT AND LONG-TERM EFFICACY BETWEEN USTEKINUMAB AND VEDOLIZUMAB IN PATIENTS WITH CROHN'S DISEASE REFRACTORY TO ANTI-TNF THERAPY
    Manlay, Luc
    Boschetti, Gilles
    Pereira, Bruno
    Buisson, Anthony
    Nancey, Stephane
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S6 - S6
  • [22] Intensification with intravenous ustekinumab in refractory Crohn′s disease
    Arroyo Arguelles, J. M.
    Suarez Ferrer, C.
    Rueda Garcia, J. L.
    Martin-Arranz, E.
    Poza Cordon, J.
    Sanchez-Azofra, M.
    Garcia-Ramirez, L.
    Martin-Arranz, M. D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 866 - 868
  • [23] Treatment of refractory cutaneous Crohn's disease with ustekinumab
    Patel, B. M.
    Rivers, C. Ramos
    Koutroumpakis, F.
    Ahsan, M.
    Dueker, J.
    Hashash, J.
    Johnston, E.
    Barrie, A.
    Harrison, J.
    Schwartz, M.
    Babichenko, D.
    Tang, G.
    Binion, D. G.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S72 - S72
  • [24] Intensification with Intravenous Ustekinumab in Refractory Crohn's Disease
    Ferrer, Cristina Suarez
    Arguelles, Jose Arroyo
    Garcia, Jose Luis Rueda
    Ramirez, Laura Garcia
    Arranz, Eduardo Martin
    Azofra, Maria Sanchez
    Cordon, Joaquin Poza
    Belda, Jesus Noci
    Martin-Arranz, Maria Dolores
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [25] USTEKINUMAB EFFICACY IN REFRACTORY BEHCET'S DISEASE
    Costa, L.
    Del Puente, A.
    Foglia, F.
    Benigno, C.
    Bottiglieri, P.
    Girolimetto, N.
    Bascherini, V
    Scotti, N.
    Schiattarella, A.
    Peluso, R.
    Scarpa, R.
    Caso, F.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (06) : S188 - S188
  • [26] Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients
    Gebeyehu, Gerum Gashaw
    Fiske, Joseph
    Liu, Eleanor
    Limdi, Jimmy K.
    Broglio, Giacomo
    Selinger, Christian
    Razsanskaite, Violeta
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (05) : 1983 - 1994
  • [27] COMPARATIVE SAFETY AND EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB IN ELDERLY CROHN'S DISEASE PATIENTS
    Gebeyehu, Gerum Gashaw
    Fiske, Joseph
    Liu, Eleanor
    Limdi, Jimmy
    Davies, Mike
    Baig, Daniyal
    Liaros, Angela
    Gaba, Waqas
    Smith, Philip
    Subramanian, Sreedhar
    [J]. GUT, 2022, 71 : A47 - A48
  • [28] The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor
    Alric, Hadrien
    Amiot, Aurelien
    Kirchgesner, Julien
    Treton, Xavier
    Allez, Mathieu
    Bouhnik, Yoram
    Beaugerie, Laurent
    Carbonnel, Franck
    Meyer, Antoine
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (10) : 948 - 957
  • [29] Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients
    Gerum Gashaw Gebeyehu
    Joseph Fiske
    Eleanor Liu
    Jimmy K. Limdi
    Giacomo Broglio
    Christian Selinger
    Violeta Razsanskaite
    Philip J. Smith
    Paul K. Flanagan
    Sreedhar Subramanian
    [J]. Digestive Diseases and Sciences, 2023, 68 : 1983 - 1994
  • [30] Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail
    Srinivasan, Ashish
    De Cruz, Peter
    van Langenberg, Daniel R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (03) : 561 - 562
12345